Supporting pharma companies to develop impactful strategies for market leadership with the customer at the centre, has been our passion at Trilations for more than 15 years.
We are taking this passion to the next level, with the introduction of the annual “Pharma customer-centricity index”. This annual global survey reveals how customer-centric top pharmaceutical companies are perceived.
This study not only includes elements on physician-centricity but also patient–centricity, customer relationship, interaction, and clinical trial performance. It provides valuable insights into the competitive environment and performance of various pharmaceutical companies on each of these topics.
“Pharma Customer-Centricity Index” scope:
- Countries: EU5 (UK, ES, IT, FR, DE), USA, Brazil, Japan, China
- Respondents: 1.422 specialists
- Treatment areas: Oncology, Haematology, Dermatology, Rheumatology, Gastroenterology
You can consult your Pharma-Customer-Centricity Index scores and those of your competing pharma companies below. If you are interested in more detailed results, want to find out what is driving these results and how to improve them, please reach out to us.
“Get closer than ever to your customers. So close that you tell them what they need well before they realize it themselves.”
“We are committed to serving the North American and LATAM markets from our new US office. Our unique expertise in fact-based HCP insights, applied in various frameworks across the entire pharma and medical device life cycle, help your brand and company succeed!”
“Trilations is possibly one of the best companies to combine Marketing Research and Consulting, with a well balanced Bottom-Up and Top-Down approach. where we can make business impact with fact-based decisions.”
I truly enjoy the fact that clients feel more secure to invest their resources in areas that drive growth & leadership. Understanding your customers starts with superior analytics, mobilizing your teams is what counts.